The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Amicus Therapeutics Inc. | Common | 03152W109 | 4,306,158 | 388,292 | SH | SOLE | 388,292 | 0 | 0 | |||
Arcutis Biotherapeutics inc | Common | 03969K108 | 2,795,507 | 254,137 | SH | SOLE | 254,137 | 0 | 0 | |||
AVROBIO, Inc. | Common | 05455M100 | 647,918 | 647,918 | SH | SOLE | 647,918 | 0 | 0 | |||
Axsome Therapeutics, Inc. | Common | 05464T104 | 4,342,395 | 70,402 | SH | SOLE | 70,402 | 0 | 0 | |||
Black Diamond Therapeutics, Inc. | Common | 09203E105 | 273,838 | 144,888 | SH | SOLE | 144,888 | 0 | 0 | |||
Chinook Therapeutics, Inc. | Common | 16961L106 | 4,579,209 | 197,806 | SH | SOLE | 197,806 | 0 | 0 | |||
Crinetics Pharmaceuticals Inc. | Common | 22663K107 | 5,787,896 | 360,392 | SH | SOLE | 360,392 | 0 | 0 | |||
Cullinan Oncology, Inc. | Common | 230031106 | 78,241,782 | 7,648,268 | SH | SOLE | 7,648,268 | 0 | 0 | |||
Geron Corporation | Common | 374163103 | 18,231,396 | 8,401,565 | SH | SOLE | 8,401,565 | 0 | 0 | |||
Harpoon Therapeutics, Inc. | Common | 41358P106 | 2,378,350 | 3,196,707 | SH | SOLE | 3,196,707 | 0 | 0 | |||
Inhibrx, Inc Com | Common | 45720L107 | 22,498,342 | 1,192,281 | SH | SOLE | 1,192,281 | 0 | 0 | |||
Inozyme Pharma Inc. | Common | 45790W108 | 1,339,261 | 233,728 | SH | SOLE | 233,728 | 0 | 0 | |||
Insmed Incorporated | Common | 457669307 | 6,806,224 | 399,192 | SH | SOLE | 399,192 | 0 | 0 | |||
Intellia Therapeutics, Inc. | Common | 45826J105 | 21,335,547 | 572,459 | SH | SOLE | 572,459 | 0 | 0 | |||
Iovance Biotherapeutics Inc Com | Common | 462260100 | 15,977,509 | 2,614,977 | SH | SOLE | 2,614,977 | 0 | 0 | |||
iTeos Therapeutics, Inc. | Common | 46565G104 | 23,762,284 | 1,745,943 | SH | SOLE | 1,745,943 | 0 | 0 | |||
Iveric Bio Inc | Common | 46583P102 | 25,441,662 | 1,045,691 | SH | SOLE | 1,045,691 | 0 | 0 | |||
Madrigal Pharmaceuticals inc | Common | 558868105 | 8,730,566 | 36,038 | SH | SOLE | 36,038 | 0 | 0 | |||
Oncorus, Inc. | Common | 68236R103 | 817,699 | 2,377,031 | SH | SOLE | 2,377,031 | 0 | 0 | |||
Phathom Pharmaceuticals inc | Common | 71722W107 | 1,518,071 | 212,615 | SH | SOLE | 212,615 | 0 | 0 | |||
Provention Bio Inc | Common | 74374N102 | 28,288,797 | 1,173,809 | SH | SOLE | 1,173,809 | 0 | 0 | |||
Reata Pharmaceuticals inc-a | Common | 75615P103 | 16,544,794 | 176,874 | SH | SOLE | 176,874 | 0 | 0 | |||
REGENXBIO Inc. | Common | 75901B107 | 11,680,159 | 617,671 | SH | SOLE | 617,671 | 0 | 0 | |||
Relay Therapeutics Inc. | Common | 75943R102 | 20,186,192 | 1,225,634 | SH | SOLE | 1,225,634 | 0 | 0 | |||
Repare Therapeutics, Inc. | Common | 760273102 | 16,136,114 | 1,639,849 | SH | SOLE | 1,639,849 | 0 | 0 | |||
Revolution Medicines, Inc. | Common | 76155X100 | 5,350,497 | 247,022 | SH | SOLE | 247,022 | 0 | 0 | |||
TCR2 Therapeutics, Inc. | Common | 87808K106 | 5,056,473 | 3,370,982 | SH | SOLE | 3,370,982 | 0 | 0 | |||
Travere Therapeutics Inc. | Common | 89422G107 | 7,053,809 | 313,642 | SH | SOLE | 313,642 | 0 | 0 | |||
Uniqure N.V. | Common | N90064101 | 7,013,231 | 348,224 | SH | SOLE | 348,224 | 0 | 0 | |||
Verve Therapeutics, Inc | Common | 92539P101 | 11,586,484 | 803,501 | SH | SOLE | 803,501 | 0 | 0 | |||
Werewolf Therapeutics, Inc. | Common | 95075A107 | 6,208,829 | 2,388,011 | SH | SOLE | 2,388,011 | 0 | 0 |